{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:34:17Z","timestamp":1769168057897,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1097\/md.0000000000008252","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T21:45:17Z","timestamp":1507671917000},"page":"e8252","source":"Crossref","is-referenced-by-count":5,"title":["Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer"],"prefix":"10.1097","volume":"96","author":[{"given":"Ying","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20210309","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S1470-2045(13)70567-9","article-title":"Breast cancer in China","volume":"15","author":"Fan","year":"2014","journal-title":"Lancet Oncol"},{"key":"R2-22-20210309","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"R3-22-20210309","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM199605233342102","article-title":"The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer","volume":"334","author":"Recht","year":"1996","journal-title":"N Engl J Med"},{"key":"R4-22-20210309","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2005.06.040","article-title":"A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer","volume":"64","author":"Arcangeli","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-22-20210309","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2005.10.011","article-title":"A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results","volume":"64","author":"Rou\u00ebss\u00e9","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-22-20210309","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1756-0500-3-247","article-title":"Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: a retrospective cohort study in a single institution","volume":"3","author":"Ismaili","year":"2010","journal-title":"BMC Res Notes"},{"key":"R7-22-20210309","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1748-717X-4-12","article-title":"Concurrent chemoradiotherapy in adjuvant treatment of breast cancer","volume":"4","author":"Ismaili","year":"2009","journal-title":"Radiat Oncol"},{"key":"R8-22-20210309","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1200\/JCO.2003.04.171","article-title":"Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review","volume":"21","author":"Huang","year":"2003","journal-title":"J Clin Oncol"},{"key":"R9-22-20210309","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijrobp.2008.04.066","article-title":"Radiotherapy timing in 4,820 patients with breast cancer: university of florence experience","volume":"73","author":"Livi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-22-20210309","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.2000.18.15.2817","article-title":"Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation","volume":"18","author":"Katz","year":"2000","journal-title":"J Clin Oncol"},{"key":"R11-22-20210309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0959-8049(11)70097-1","article-title":"Synchronous chemo-radiation can reduce local recurrence in early stage breast cancer: results of the SECRAB Trial (ISRCTN: 84214355) presented on behalf of the SECRAB Steering Committee","volume":"47","author":"Fernando","year":"2011","journal-title":"Eur J Cancer"},{"key":"R12-22-20210309","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.2006.07.8576","article-title":"Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial","volume":"25","author":"Toledano","year":"2007","journal-title":"J Clin Oncol"},{"key":"R13-22-20210309","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/030089161009600105","article-title":"The sequencing of chemotherapy and radiotherapy in breast cancer patients after mastectomy","volume":"96","author":"Kim","year":"2010","journal-title":"Tumori"},{"key":"R14-22-20210309","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2407-8-114","article-title":"Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy\u2014a retrospective analysis","volume":"8","author":"Piroth","year":"2008","journal-title":"BMC Cancer"},{"key":"R15-22-20210309","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa071167","article-title":"HER2 and response to paclitaxel in node-positive breast cancer","volume":"357","author":"Hayes","year":"2007","journal-title":"N Engl J Med"},{"key":"R16-22-20210309","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1634\/theoncologist.2011-0442","article-title":"Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial","volume":"17","author":"Coudert","year":"2012","journal-title":"Oncologist"},{"key":"R17-22-20210309","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2012.46.9841","article-title":"Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM\/2003-02 study","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"R18-22-20210309","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2010.02.013","article-title":"Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation","volume":"95","author":"Greenbaum","year":"2010","journal-title":"Radiother Oncol"},{"key":"R19-22-20210309","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3322\/caac.21209","article-title":"Progress and controversies: radiation therapy for invasive breast cancer","volume":"64","author":"Jagsi","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R20-22-20210309","first-page":"854","article-title":"Comparison of the effect of synchronous chemoradiotherapy and sequential schedule as adjuvant therapy after surgery in locally advanced breast cancer","volume":"21","author":"Lu","year":"2014","journal-title":"Chin J Cancer Prev Treat"},{"key":"R22-22-20210309","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-22-20210309","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/030089161109700304","article-title":"Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer","volume":"97","author":"Kim","year":"2011","journal-title":"Tumori"},{"key":"R24-22-20210309","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"R25-22-20210309","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijrobp.2005.07.975","article-title":"Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer","volume":"64","author":"Burstein","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-22-20210309","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2010.08.051","article-title":"A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer","volume":"82","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R27-22-20210309","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/0284186X.2013.871387","article-title":"Radiation-induced lung injury after concurrent neoadjuvant chemoradiotherapy for locally advanced breast cancer","volume":"53","author":"Chow","year":"2014","journal-title":"Acta Oncol"},{"key":"R28-22-20210309","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","article-title":"Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741\/Cancer and Leukemia Group B Trial 9741","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol"},{"key":"R29-22-20210309","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.2015.60.9271","article-title":"Long-term follow-up of the E1199 Phase III trial evaluating the role of taxane and schedule in operable breast cancer","volume":"33","author":"Sparano","year":"2015","journal-title":"J Clin Oncol"},{"key":"R30-22-20210309","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00432-013-1478-1","article-title":"Relative and disease-free survival for breast cancer in relation to subtype: a population-based study","volume":"139","author":"Minicozzi","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"R31-22-20210309","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10549-010-1181-8","article-title":"Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival","volume":"124","author":"Adams","year":"2010","journal-title":"Breast Cancer Res Treat"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:36:10Z","timestamp":1620959770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201710130-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008252","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}